The study in Nature Medicine explores the potential wider benefits and risks of diabetes drugs GLP-1 receptor agonists.

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including ...

The use of weight-loss jabs may be associated with wider health benefits including lower risk of stroke and dementia, a study ...

The market for GLP-1 drugs is projected to exceed $200 billion in annual sales by 2031, according to Morningstar Equity Research. Current market leaders include Novo Nordisk NVO and Eli Lilly LLY with ...

A study has suggested that the use of weight-loss jabs may be associated with wider health benefits, including a lower risk ...

Researchers have found links to multiple new benefits – and new side effects – in a study of weight-loss drugs such as ...

A major new study has highlighted significant health risks associated with popular weight loss injections such as Ozempic, ...

WEIGHT loss jabs protect against dozens of illnesses but raise the chances of 19 others, a study shows. Demand has rocketed ...

A Conservative former minister said he has lost more than five stone in weight after using weight-loss injections, as he ...

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including dementia and cardiovascular diseases, although experts warned against seeing ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat substance abuse disorders, psychosis, infections, cancer, and dementia.

Tirzepatide, the main ingredient in Mounjaro and Zepbound ... the main ingredient in the type 2 diabetes drug Ozempic and the weight loss drug Wegovy. Semaglutide remains on the FDA’s shortage ...